VIG
GILD icon

Vienna Insurance Group’s Gilead Sciences GILD Stock Holding History

Vienna Insurance Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-60,000
Closed -$4.08M – 21
2017
Q1 		$4.08M Buy
+60,000
New +$4.22M 3.95% 12

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vienna Insurance Group's GILD Position: Q2 2017 in Review

Vienna Insurance Group sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 60,000 shares — an estimated $4.08M sold.

Vienna Insurance Group first reported a position in GILD in Q1 2017 and held it in 1 quarter. The position peaked at $4.08M in Q1 2017. 1,520 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Vienna Insurance Group reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
  • Vienna Insurance Group sold 60,000 Gilead Sciences shares in Q2 2017, an estimated $4.08M.
  • Vienna Insurance Group first reported a position in Gilead Sciences in Q1 2017 and held it in 1 quarter.
  • Vienna Insurance Group's Gilead Sciences position peaked at $4.08M in Q1 2017.
  • 1,520 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Vienna Insurance Group's 13F filing for Q2 2017, filed 4 Sep 2024.